Epidermolysis bullosa acquisita: Concise review and practical considerations

International Journal of Dermatology

Volumn 48, Issue 3, 2009, Pages 227-236

  Lehman, Julia S ^a   Camilleri, Michael J ^a   Gibson, Lawrence E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; COLLAGEN TYPE 4; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID;

BLISTER; CLINICAL FEATURE; CONFOCAL LASER MICROSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; HISTOPATHOLOGY; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PATIENT MONITORING; PHOTOCHEMOTHERAPY; PROGNOSIS; REVIEW; SKIN BIOPSY; UNSPECIFIED SIDE EFFECT;

ALGORITHMS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMANS; SKIN;

EID: 61349183228     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03886.x     Document Type: Review

References (52)

1. Woodley DT, Briggaman RA, O'Keefe EJ, et al. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984;310:1007-1013.
2. Woodley DT, Burgeson RE, Lunstrum G, et al. The epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988;81:683-687.
3. Woodley DT, Chang C, Saadat P, et al. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005;124:958-964.
4. Lapiere JC, Woodley DT, Parente MG, et al. Epitope mapping of type VII collagen: Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993;92:1831-1839.
5. Ishii N, Yoshida M, Hisamatsu Y, et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: Study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 2004;150:843-851.
6. Chen M, Doostan A, Bandyopadhyay P, et al. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 2007;170:2009-2018.
7. Elliott GT. Two cases of epidermolysis bullosa. J Cutan Genitourin 1895;13:10.
8. Roenigk HH Jr, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita: report of three cases and review of all published cases. Arch Dermatol 1971;103:10.
9. Richter BJ, McNutt NS. The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979;115:1325.
10. Palestine RF, Kossard S, Dicken CH. Epidermolysis bullosa acquisita: A heterogeneous disease. J Am Acad Dermatol 1981;5:43-53.
11. Gammon WR, Briggaman RA, Wheeler CE Jr. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol 1982;7:382-387.
12. Mutasim DF, Bilic M, Hawayek LH, et al. Immunobullous diseases. J Am Acad Dermatol 2005;52:1029-1043.
13. Woodley DT, Sarret Y, Briggaman RA. Autoimmunity to type VII collagen. Semin Dermatol 1991;10:232-239.
14. Kurzhals G, Stolz W, Meurer M et al. Acquired epidermolysis bullosa with the clinical features of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 1991;127:391.
15. Cox NH, Bearn MA, Herold J, et al. Blindness due to the IgA variant of epidermolysis bullosa acquisita, and treatment with osteo-odonto-keratoprosthesis. Br J Dermatol 2007;156:775-777.
16. Espana A, Sitaru C, Pretel M, et al. Erythema gyratum repens-like eruption in a patient with epidermolysis bullosa acquisita associated with ulcerative colitis. Br J Dermatol 2007;156:773-775.
17. Callot-Mellot C, Bodemer C, Caux F, et al. Epidermolysis bullosa acquisita in childhood. Arch Dermatol 1997;133:1122-1126.
18. Trigo-Guzman FX, Conti A, Aoki V, et al. Epidermolysis bullosa acquisita in childhood. J Dermatol 2003;30:226-229.
19. Chorzelski T, Karczewska K, Dyduch A, et al. Epidermolysis bullosa acquisita in a 4-year old boy. Pediatr Dermatol 2000;17:157-158.
20. Woodley DT, Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1999:702-709.
21. Nieboer C, Boorsma DM, Woerdeman MJ et al. Epidermolysis bullosa acquisita: Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol 1980;102:383.
22. Yaoita H, Briggaman RA, Lawley TJ et al. EBA: Ultrastructural and immunological studies. J Invest Dermatol 1981;76:288.
23. Smoller BR, Woodley DT. Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid. J Am Acad Dermatol 1992;27(5 Part 1):674-678.
24. Peters MS, Rogers RS. Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone. J Am Acad Dermatol 1989;20(5 Part 1):761-770.
25. Vodegel RM, Jonkman MF, Pas HH, et.al. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 2004;151:112-118.
26. Gammon WR, Kowalewski C, Chorzelski TP, et al. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990;22:1990.
27. Feliciani C, Muzio M, Mohammed Pour S, et al. "Suction split"as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid. J Eur Acad Dermatol Venereol 1998;10:243-247.
28. Rinaldi CJ, Camilleri MJ. The role of collagen IV immunomapping in the evaluation of cutaneous autoimmune subepidermal blistering disorders. J Am Acad Dermatol 2008;58: AB85 poster abstract, AAD 66th Annual Meeting.
29. Fine JD, Tyring S, Gammon WR. The presence of intralamina lucida blister formation in epidermolysis bullosa acquisita: Possible role of leukocytes. J Invest Dermatol 1989;92:27-32.
30. Wozniak K, Kazama T, Kowalewski C. A practical technique for differentiation of subepidermal bullous disease: Localization of in vivo -bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003;139:1007-1011.
31. Wozniak K, Kowalewski C. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases. J Dermatol Sci 2005;40:169-175.
32. Ishiko A, Shimizu H. Electron microscopy in diagnosis of autoimmune bullous disorders. Clin Dermatol 2001;19:631-637.
33. Kushniruk W. The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J 1973;108:1143.
34. Gammon WR, Briggaman RA, Inman AO 3rd et.al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984;82:139-144.
35. Vodegel RM, de Jong MC, Pas HH, et.al. Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: Differentiation by use of indirect immunofluorescence microscopy. J Am Acad Dermatol 2003;48:542-547.
36. McMillan JR, Matsumura T, Hashimoto T, et al. Immunomapping of EBA sera to multiple epitopes on collagen VII: Further evidence that anchoring fibrils originate and terminate in the lamina densa. Exp Dermatol 2003;12:261-267.
37. Chen M, Chan LS, Cai X, et al. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997;108:68-72.
38. Dahl MGC. Epidermolysis bullosa acquisita: A sign of cicatricial pemphigoid? Br J Dermatol 1979;101:475-484.
39. Stewart MI, Woodley DT, Briggaman RA. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Arch Dermatol 1991;127:373-377.
40. Miyagawa S, Iida T, Hachisuka H, et al. Epidermolysis bullosa acquisita with oesophageal stenosis. Br J Dermatol 1992;127:172-176.
41. Kirtschig G, Murrell D, Wojnarowska F, et.al. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev 2003;1:CD004056.
42. Engineer L, Ahmed AR. Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 2001;44:818-828.
43. Abecassis S, Joly P, Genereau T, et al. Superpotent topical steroid therapy for epidermolysis bullosa acquisita. Dermatol 2004;209:164-166.
44. Marzano AV, Dassoni F, Caputo R. Treatment of refractory blistering autoimmune diseases with mycophenolic acid. J Dermatolog Treat 2006;17:370-376.
45. Kowalzick L, Suckow S, Ziegler H, et al. Mycophenolate mofetil in epidermolysis bullosa acquisita. Dermatol 2003;207:332-334.
46. Hughes AP, Callen JP. Epidermolysis bullosa acquisita responsive to dapsone therapy. J Cutan Med Surg 2001;5:397-399.
47. Schmidt E, Benoit S, Brocker E-B, et.al. Successful adjuvant treatment of recalcitrant EBA with anti-CD-20 antibody rituximab. Arch Dermatol 2006;142:147-150.
48. Niedermeier A, Eming R, Pfütze M, et al. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies). Arch Dermatol 2007;143:192-198.
49. Sadler E, Schafleitner B, Lanschuetzer C, et al. Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab. Br J Dermatol 2007;157:417-419.
50. Crichlow SM, Mortimer NJ, Harman KE. A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita. Br J Dermatol 2007;156:194-196.
51. Chan LS, Chen M, Woodley DT. Epidermolysis bullosa acquisita in the elderly. J Geriatr Dermatol 1996;4:47-52.
52. Chen M, O'Toole EA, Sanghavi J, et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002;118:1059-1064.